NFE2L2 and pancreatic neoplasm: The significance of our findings lies in two aspects: first, we identified CPEB1 as a ferroptosis modulator critical for therapeutic response in pancreatic cancer; and second, we revealed that p62 and NRF2 are essential downstream targets of CPEB1, mediating the regulation of ferroptosis susceptibility.